Ridder, D., Urbansky, L. L., Witzel, H. R., Schindeldecker, M., Weinmann, A., Berndt, K., . . . Straub, B. K. (2022). Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcome. Cancers, 14(2), . https://doi.org/10.3390/cancers14020430
Chicago-Zitierstil (17. Ausg.)Ridder, Dirk, et al. "Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome." Cancers 14, no. 2 (2022). https://doi.org/10.3390/cancers14020430.
MLA-Zitierstil (9. Ausg.)Ridder, Dirk, et al. "Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome." Cancers, vol. 14, no. 2, 2022, https://doi.org/10.3390/cancers14020430.